High prevalence of T354P sodium/iodide symporter gene mutation in Japanese patients with iodide transport defect who have heterogeneous clinical pictures.
High prevalence of T354P sodium/iodide symporter gene mutation in Japanese patients with iodide transport defect who have heterogeneous clinical pictures.
复制标题
在具有异质临床表现的碘转运缺陷日本患者中,T354P 钠/碘同向转运蛋白基因突变的患病率较高。
DOI:
--
复制
发表时间:
1998
影响因子:
5.8
通讯作者:
S. Jhiang
中科院分区:
文献类型:
--
作者:
S. Kosugi;Y. Sato;A. Matsuda;Y. Ohyama;K. Fujieda;H. Inomata;T. Kameya;O. Isozaki;S. Jhiang
A missense and loss of function mutation of the Na+/I- symporter (NIS) gene, T354P [Thr354-->Pro (ACA-->CCA)], was found in the homozygous state in two unrelated Japanese patients with iodide transport defect. In this study we have identified the homozygous T354P NIS germline mutation in seven Japanese patients, including one previously reported, from five unrelated families. No other nucleotide changes were found in the coding regions and the exon-intron boundaries of the NIS gene in these seven patients. These results suggest a common prevalence of the T354P mutation in Japanese patients. Although these seven patients have the identical NIS mutation, T354P, marked heterogeneity in clinical pictures, especially concerning goiter and hypothyroidism, were noted among them. Therefore, another factor(s), but not the nature of the NIS mutation, may account for the clinical heterogeneity among patients with the iodide transport defect. We have previously reported that the NIS messenger ribonucleic acid was markedly increased in the thyroid of a patient with the homozygous T354P mutation. In this study we demonstrated that the NIS proteins in the patients' thyroids were significantly increased (approximately 10-fold) by Western blot analysis of integral membrane proteins using an antibody against the C-terminal peptide of the human NIS. Furthermore, we showed by immunohistochemical staining that the T354P mutant NIS proteins were overexpressed in the basal and lateral plasma membranes of patients' thyrocytes.
登录
查看更多内容
DOI:
10.1172/jci1504
发表时间:
1998
期刊:
The Journal of clinical investigation
影响因子:
--
作者:
Pohlenz,J;Rosenthal,IM;Weiss,RE;Jhiang,SM;Burant,C;Refetoff,S
通讯作者:
Refetoff,S
影响因子:
4.8
作者:
P. Smanik;Kwon-Yul Ryu;Karl S. Theil;Ernest L. Mazzaferri;S. Jhiang
通讯作者:
P. Smanik;Kwon-Yul Ryu;Karl S. Theil;Ernest L. Mazzaferri;S. Jhiang
DOI:
10.1006/bbrc.1996.1358
发表时间:
1996-09-13
影响因子:
3.1
作者:
Smanik, PA;Liu, Q;Jhiang, SM
通讯作者:
Jhiang, SM
DOI:
10.1073/pnas.94.11.5568
发表时间:
1997-05-27
影响因子:
11.1
作者:
Levy, O;Dai, G;Carrasco, N
通讯作者:
Carrasco, N
DOI:
10.1006/bbrc.1997.7594
发表时间:
1997-11-17
影响因子:
3.1
作者:
Pohlenz, J;MedeirosNeto, G;Refetoff, S
通讯作者:
Refetoff, S